New Study Suggests That Drug MDMA Can Reduce Symptoms Of PTSD
According to a new study published on Thursday, the psychedelic drug MDMA can reduce symptoms of post-traumatic stress disorder. The company sponsoring the research, MAPS Public Benefit Corporation, said it plans to seek U.S. approval to market the drug at the end of the year. “It’s the first innovation in PTSD treatment in more than two decades,” said CEO of MAPS Public Benefit Corporation Amy Emerson in a statement. “And it’s significant because I think it will also open up other innovations.” To conduct the study, researchers examined the symptoms of 104 patients with PTSD, some of whom wer...